CI · Cigna Group
$270.46
-3.59 (-1.31%)
At close · Aug 5
Market Cap
$71.53B
Shares
264.24M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$3,200,000,000
as of 2024-02-15
· not restated in filings since 2025-02-27
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $280,000,000 | 10-Q, filed 2026-07-30 |
| 2025-12-31 | $3,621,000,000 | 10-K, filed 2026-02-26 |
| 2024-12-31 | $7,034,000,000 | 10-K, filed 2026-02-26 |
| 2023-12-31 | $2,284,000,000 | 10-K, filed 2026-02-26 |
| 2022-12-31 | $7,607,000,000 | 10-K, filed 2025-02-27 |
| 2021-12-31 | $7,742,000,000 | 10-K, filed 2024-02-29 |
| 2020-12-31 | $4,042,000,000 | 10-K, filed 2023-02-23 |
| 2019-12-31 | $1,987,000,000 | 10-K, filed 2022-02-24 |
| 2018-12-31 | $342,000,000 | 10-K, filed 2021-02-25 |
| 2017-12-31 | $2,725,000,000 | 10-K, filed 2020-02-27 |
| 2016-12-31 | $139,000,000 | 10-K, filed 2019-02-28 |
Key facts
CIK
1739940
CUSIP
125523100
13F (30d)
825 filings
797 filers
Visit website
Investor relations